Nitazoxanide / Ofloxacin Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 500mg + 200mg
Reference Brands: Various Indian Brand Available
Category:
Anthelmintic
Nitazoxanide + Ofloxacin is a combination of two medicines: Nitazoxanide and Ofloxacin. Nitazoxanide is an antiparasitic. It works by interfering with the energy metabolism of parasites, which ultimately causes their death. Ofloxacin kills bacteria by preventing them from reproducing and repairing themselves. Together, they treat your infection effectively.
Nitazoxanide / Ofloxacin Tablet is available in Tablets
and strengths such as 500mg + 200mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Nitazoxanide / Ofloxacin Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Nitazoxanide / Ofloxacin Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Nitazoxanide and Ofloxacin combination is a prescription medication formulated to treat mixed intestinal infections, including bacterial diarrhea, dysentery, and protozoal infestations such as giardiasis. This combination brings together nitazoxanide, an anti-protozoal agent that disrupts the energy metabolism of parasites, and ofloxacin, a broad-spectrum fluoroquinolone antibiotic that inhibits bacterial DNA replication, effectively eliminating pathogenic bacteria in the gastrointestinal tract.
The dual-action mechanism makes this combination highly effective against infections caused by both bacteria and protozoa, providing rapid relief from symptoms such as diarrhea, abdominal cramps, and dehydration. It is typically administered orally over a short course of about three days, ensuring convenience and compliance for patients while reducing the risk of prolonged infection.
This combination is widely used in regions where mixed intestinal infections are common, offering a targeted approach to managing gastrointestinal disorders. By addressing both bacterial and protozoal causes simultaneously, it helps restore intestinal health, prevent complications, and improve overall patient recovery. Proper medical supervision is essential to ensure safe and effective use, as the combination contains potent antibacterial and antiparasitic agents.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing